1 | Page
Introductory Clinical Pharmacology 12th Edition Test Bank
| Comprehensive 150-Question Practice Examination with
Verified Answers and Detailed Rationales 2026–2027 |
Nursing Pharmacology Comprehensive Exam Prep | Graded
A+ | 100% Pass Guaranteed
Description: This comprehensive 150-question test bank is designed for
nursing students using the Introductory Clinical Pharmacology 12th
Edition by Susan M. Ford. The assessment covers all major content
areas including pharmacokinetics, pharmacodynamics, drug
administration safety, medication calculations, and drug classifications
across all body systems. Based on current evidence-based practice and
nursing standards, this exam tests both foundational knowledge and
clinical application expected of competent nursing students preparing for
pharmacology examinations and NCLEX.
SECTION 1: QUESTIONS 1-50
Question 1
Pharmacokinetics describes how the body handles a drug. Which
process is NOT one of the four classic pharmacokinetic phases?
A) Absorption
,2 | Page
B) Distribution
C) Metabolism
D) Immunization
Answer: D
Rationale: The four classic pharmacokinetic phases are absorption,
distribution, metabolism, and excretion. Immunization is not a
pharmacokinetic process. Pharmacokinetics studies the movement of
drugs through the body, including how they are absorbed, distributed,
metabolized, and eliminated. The term ADME is commonly used to
remember these four processes.
---
Question 2
First-pass metabolism primarily occurs in which organ?
A) Kidneys
B) Liver
C) Lungs
D) Small intestine
Answer: B
,3 | Page
Rationale: First-pass metabolism primarily occurs in the liver. When a
drug is absorbed from the gastrointestinal tract, it passes through the
portal vein to the liver before reaching systemic circulation. The liver
metabolizes a significant portion of the drug, reducing its bioavailability.
This is why some drugs cannot be given orally because they are
extensively metabolized before reaching their target sites.
---
Question 3
Bioavailability is best defined as:
A) The fraction of administered drug that reaches systemic circulation
unchanged
B) The rate of drug elimination by the kidneys
C) The time for plasma concentration to halve
D) Drug potency compared to standard
Answer: A
Rationale: Bioavailability is the fraction of an administered dose of drug
that reaches the systemic circulation unchanged. It is influenced by
factors such as first-pass metabolism, drug formulation, and route of
administration. A drug given intravenously has 100 percent
bioavailability because it enters systemic circulation directly. Oral drugs
, 4 | Page
typically have lower bioavailability due to incomplete absorption and
first-pass metabolism.
---
Question 4
The half-life (t) of a drug affects which clinical parameter?
A) Dosing interval
B) Site of action
C) Route of administration only
D) Drug taste
Answer: A
Rationale: The half-life of a drug determines the dosing interval. A drug
with a short half-life requires more frequent dosing to maintain
therapeutic levels. A drug with a long half-life can be given less
frequently. Half-life is the time required for the plasma concentration of
a drug to decrease by 50 percent. It is an important pharmacokinetic
parameter that guides dosing schedules.
---
Question 5
Introductory Clinical Pharmacology 12th Edition Test Bank
| Comprehensive 150-Question Practice Examination with
Verified Answers and Detailed Rationales 2026–2027 |
Nursing Pharmacology Comprehensive Exam Prep | Graded
A+ | 100% Pass Guaranteed
Description: This comprehensive 150-question test bank is designed for
nursing students using the Introductory Clinical Pharmacology 12th
Edition by Susan M. Ford. The assessment covers all major content
areas including pharmacokinetics, pharmacodynamics, drug
administration safety, medication calculations, and drug classifications
across all body systems. Based on current evidence-based practice and
nursing standards, this exam tests both foundational knowledge and
clinical application expected of competent nursing students preparing for
pharmacology examinations and NCLEX.
SECTION 1: QUESTIONS 1-50
Question 1
Pharmacokinetics describes how the body handles a drug. Which
process is NOT one of the four classic pharmacokinetic phases?
A) Absorption
,2 | Page
B) Distribution
C) Metabolism
D) Immunization
Answer: D
Rationale: The four classic pharmacokinetic phases are absorption,
distribution, metabolism, and excretion. Immunization is not a
pharmacokinetic process. Pharmacokinetics studies the movement of
drugs through the body, including how they are absorbed, distributed,
metabolized, and eliminated. The term ADME is commonly used to
remember these four processes.
---
Question 2
First-pass metabolism primarily occurs in which organ?
A) Kidneys
B) Liver
C) Lungs
D) Small intestine
Answer: B
,3 | Page
Rationale: First-pass metabolism primarily occurs in the liver. When a
drug is absorbed from the gastrointestinal tract, it passes through the
portal vein to the liver before reaching systemic circulation. The liver
metabolizes a significant portion of the drug, reducing its bioavailability.
This is why some drugs cannot be given orally because they are
extensively metabolized before reaching their target sites.
---
Question 3
Bioavailability is best defined as:
A) The fraction of administered drug that reaches systemic circulation
unchanged
B) The rate of drug elimination by the kidneys
C) The time for plasma concentration to halve
D) Drug potency compared to standard
Answer: A
Rationale: Bioavailability is the fraction of an administered dose of drug
that reaches the systemic circulation unchanged. It is influenced by
factors such as first-pass metabolism, drug formulation, and route of
administration. A drug given intravenously has 100 percent
bioavailability because it enters systemic circulation directly. Oral drugs
, 4 | Page
typically have lower bioavailability due to incomplete absorption and
first-pass metabolism.
---
Question 4
The half-life (t) of a drug affects which clinical parameter?
A) Dosing interval
B) Site of action
C) Route of administration only
D) Drug taste
Answer: A
Rationale: The half-life of a drug determines the dosing interval. A drug
with a short half-life requires more frequent dosing to maintain
therapeutic levels. A drug with a long half-life can be given less
frequently. Half-life is the time required for the plasma concentration of
a drug to decrease by 50 percent. It is an important pharmacokinetic
parameter that guides dosing schedules.
---
Question 5
